Gainers:
GENFIT S A/ADR GNFT shares are up 9% after announcing a strategic partnership with Terns Pharmaceuticals to develop and commercialize elafibranor in Greater China. The company will receive an upfront payment of $35 million.
Nabriva Therapeutics PLC - ADR NBRV shares are up 3% after reporting the EMA validated the marketing authorization application for lufamulin.
Losers:
Conatus Pharmaceuticals Inc CNAT shares are down 57% after reporting that top-line results from the ENCORE-LF trial of emricasan did not meet the primary endpoint and will discontinue further treatment of patients enrolled.
Gamida Cell Ltd GMDA shares are down 10% after the company filed for a common stock offering of 4.04 million shares.
Krystal Biotech Inc KRYS shares are down 4% after filing for a $100-million common stock offering.
Mirati Therapeutics Inc MRTX shares are down 2% after reporting a common stock offering. The size was not disclosed.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.